Patient-Reported Outcomes After Treatment Discontinuation: Commercial Clinical Trial Data From Four Cancer Types

How frequently patient-reported outcome (PRO) data are collected in commercial cancer clinical trials after treatment discontinuation and the quality of that data are poorly understood. We reviewed treatment discontinuation follow-up PRO data collection to learn about trials collecting these data and understand data quality. The review included 4 cancer types representing potential for long- (prostate cancer), medium-/long- (breast cancer), and short-term (pancreatic cancer and hepatocellular carcinoma) follow-up owing to disease trajectory.

Source: Value in Health - June 24, 2021 Category: International Medicine & Public Health Authors: Bellinda L. King-Kallimanis, Nirosha Mahendraratnam Lederer, Janice Kim, Abhilasha Nair, Erica Horodniceanu, Vishal Bhatnagar, Paul G. Kluetz Tags: Patient-Reported Outcomes Source Type: research